The Clorox Company CLX NYSE

The Clorox Company (CLX) reported total assets of $5.56B and total liabilities of $5.08B for fiscal year 2025, resulting in total equity of $482M.

The company held $167M in cash and short-term investments. Total debt stood at $2.88B, with net debt of $2.71B. The Debt-to-Equity (D/E) ratio was 5.98 (leveraged).

Current ratio is 0.84, which may signal tight short-term liquidity. Interest coverage is 11.7x (strong).

Criteria supported by this page:

• HEALTH (33/100, Fail) — the balance sheet shows elevated risk in debt or liquidity metrics
• MOAT (73/100) — Total assets $5.56B and equity $482M support the company's competitive scale
• VALUE (80/100) — Debt-to-Equity 5.98 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 66/100 with 4/7 criteria passed.

PG

The Procter & Gamble Company

$144.40

+0.57%

UL

Unilever PLC

$57.81

-0.72%

CL

Colgate-Palmolive Company

$84.16

+0.21%

RBGLY

Reckitt Benckiser Group plc

$13.83

+0.44%

KMB

Kimberly-Clark Corporation

$97.16

+0.58%

EL

The Estée Lauder Companies Inc.

$76.42

+2.51%

CHD

Church & Dwight Co., Inc.

$95.53

+0.53%

SGI

Somnigroup International Inc

$81.84

+2.45%